ISRCTN11853110
Completed
Phase 3
Randomised controlled trial of the clinical and cost effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in treatment seeking patients with moderate severity depressive episodes in primary care
niversity of Nottingham0 sites236 target enrollmentAugust 14, 2020
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Nottingham
- Enrollment
- 236
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35379314/ (added 05/10/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36724796/ (added 02/02/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged \=16 years
- •2\. Diagnosis of current Major Depressive Episode (MDE)
- •3\. A Score of \=10 or 9\-item self\-rated Personal Health Questionnaire (PHQ\-9\)
- •4\. Have either been offered the option of anti\-depressant medication or prescribed antidepressant medication for a minimum of 6 weeks in the last 3 months
- •5\. Capable of giving oral and written informed consent to the study, and this consent is confirmed by the researcher at eligibility screening and baseline assessment
- •6\. Agrees to return Alpha\-Stim equipment at the end of the study and not to purchase this equipment privately during the study
Exclusion Criteria
- •1\. A score of \=20 on the PHQ\-9
- •2\) Neurological conditions e.g. brain neoplasm, cerebrovascular events, epilepsy, neurodegenerative disorders, and prior brain surgery
- •3\. Requiring urgent clinical care such as having persistent suicidal ideation, self\-harm or suicidal intent.
- •4\. Known to be pregnant
- •5\. Implantation with a pacemaker or an implantable cardioverter device (ICD)
- •6\. Major unstable medical illness requiring further investigation or treatment
- •7\. A diagnosis of current substance use disorder or dependence, dementia, eating disorder, bipolar disorder or nonaffective psychosis because the use of CES treatment would otherwise require additional supervision or is associated with additional risk e.g. of mania in bipolar disorder
- •8\. Completed and benefitted from/responded to psychological treatment for depression in the last 3 months or planning to commence psychological treatment in the next 6 months
- •9\. Involved with any other clinical trial at the time of consent or 6 months prior
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Does screening with the Galleri test in the NHS reduce the likelihood of a late-stage cancer diagnosis?Multi cancer early detection in people without symptomsCancerISRCTN91431511GRAIL Bio UK Ltd.140,000
Completed
Not Applicable
Randomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter-associated complications in adults living with long-term cathetersISRCTN17116445HS Grampian80
Active, not recruiting
Not Applicable
Effects of an e-health intervention ‘iSupport’ for reducing distress of dementia carersISRCTN17420703Bangor University352
Completed
Not Applicable
iTEFORM light therapy effectiveness for oral mucositisISRCTN14224600The Newcastle Upon Tyne Hospitals NHS Foundation Trust380
Active, not recruiting
Not Applicable
A clinical trial looking at maintaining hydration at the end of lifeISRCTN65858561niversity of Surrey1,600